For nearly 200 years, USP’s public standards have served to establish a common foundation upon which the quality of medicines can be evaluated, building trust in the healthcare system and enabling innovation to thrive. During that time, medicine has evolved tremendously.
With growing concerns about the availability of medical appointments and medicines in these days of COVID-19, people are relying more and more on dietary supplements to support their health. According to IRI – a market research firm that tracks U.S.
I was pleased to address the American Association of Pharmaceutical Scientists (AAPS) on May 12 during a webinar focused on the impact of the COVID-19 pandemic on the supply of quality medicines.